SEC Form 4 · accession 0001249872-16-000007
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Roberts
Officer — Chief Operating Officer
Period of report
Jul 11, 2016
Accepted (ET)
Jul 13, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.04 | Jul 11, 2016 | A | 120,000 | A | — | Jul 11, 2026 | Common Stock, par value $0.0001 per share | 120,000 | 120,000 | D |
Explanation of responses
- F1The shares underlying the option shall vest as follows: 2,500 options vesting on the date of grant and the remaining 117,500 options vesting in equal monthly installments of 2,500 shares commencing one month following the date of grant until fully vested, provided that the reporting person remains a service provider to Cancer Genetics, Inc. through each applicable vesting period.